AAAAAA

   
Results: 1-10 |
Results: 10
Diagnostic brain MRI findings in primary progressive multiple sclerosis
Authors: Kremenchutzky, M Lee, D Rice, GPA Ebers, GC
Citation: M. Kremenchutzky et al., Diagnostic brain MRI findings in primary progressive multiple sclerosis, MULT SCLER, 6(2), 2000, pp. 81-85
Cladribine and progressive MS - Clinical and MRI outcomes of a multicentercontrolled trial
Authors: Rice, GPA Filippi, M Comi, G
Citation: Gpa. Rice et al., Cladribine and progressive MS - Clinical and MRI outcomes of a multicentercontrolled trial, NEUROLOGY, 54(5), 2000, pp. 1145-1155
The effect of cladribine on T-1 'black hole' changes in progressive MS
Authors: Filippi, M Rovaris, M Rice, GPA Sormani, MP Iannucci, G Giacomotti, L Comi, G
Citation: M. Filippi et al., The effect of cladribine on T-1 'black hole' changes in progressive MS, J NEUR SCI, 176(1), 2000, pp. 42-44
The natural history of multiple sclerosis: a geographically based study 8:Familial multiple sclerosis
Authors: Ebers, GC Koopman, WJ Hader, W Sadovnick, AD Kremenchutzky, M Mandalfino, P Wingerchuk, DM Baskerville, J Rice, GPA
Citation: Gc. Ebers et al., The natural history of multiple sclerosis: a geographically based study 8:Familial multiple sclerosis, BRAIN, 123, 2000, pp. 641-649
Treatment of secondary progressive multiple sclerosis - Current recommendations and future prospects
Authors: Rice, GPA
Citation: Gpa. Rice, Treatment of secondary progressive multiple sclerosis - Current recommendations and future prospects, BIODRUGS, 12(4), 1999, pp. 267-277
TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study
Authors: Arnason, BGW Jacobs, G Hanlon, M Clay, BH Noronha, ABC Auty, A Davis, B Nath, A Bouchard, JP Belanger, C Gosselin, F Thibault, M Duquette, P Bourgoin, P DuBois, R Girard, M Ebers, GC Rice, GPA Vandervoort, MK Francis, GS Duncan, L Lapierre, Y Freedman, MS Christie, SN Rabinovitch, HE Patry, D Murphy, WF Peters, S McGuiness, SD Murray, TJ Bhan, V Maxner, CE Van Dorpe, R Oger, JJ Nelson, J Morrison, W Bogle, N Beall, S Vorobeychick, G Hiltbrunner, AV Bock, J",Habil,"Lesslauer, W Li, DKB Paty, DW Zhao, GJ
Citation: Bgw. Arnason et al., TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study, NEUROLOGY, 53(3), 1999, pp. 457-465
Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS
Authors: Rice, GPA Ebers, GC Lublin, FD Knobler, RL
Citation: Gpa. Rice et al., Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS, NEUROLOGY, 52(9), 1999, pp. 1893-1895
The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1b
Authors: Rice, GPA Paszner, B Oger, J Lesaux, J Paty, D Ebers, G
Citation: Gpa. Rice et al., The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1b, NEUROLOGY, 52(6), 1999, pp. 1277-1279
The natural history of multiple sclerosis: a geographically based study - 5. The clinical features and natural history of primary progressive multiple sclerosis
Authors: Cottrell, DA Kremenchutzky, M Rice, GPA Koopman, WJ Hader, W Baskerville, J Ebers, GC
Citation: Da. Cottrell et al., The natural history of multiple sclerosis: a geographically based study - 5. The clinical features and natural history of primary progressive multiple sclerosis, BRAIN, 122, 1999, pp. 625-639
The natural history of multiple sclerosis: a geographically based study - 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis
Authors: Cottrell, DA Kremenchutzky, M Rice, GPA Hader, W Baskerville, J Ebers, GC
Citation: Da. Cottrell et al., The natural history of multiple sclerosis: a geographically based study - 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis, BRAIN, 122, 1999, pp. 641-647
Risultati: 1-10 |